Full Text View
Tabular View
No Study Results Posted
Related Studies
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
This study has been completed.
Study NCT00355407   Information provided by Dana-Farber Cancer Institute
First Received: July 19, 2006   Last Updated: March 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Malignancies
Additional conditions recognized in this trial
Hematologic Neoplasms
More general conditions related to this trial
Hematologic Diseases
Neoplasms
Neoplasms by Site
Interventions listed in this trial
Darbepoetin alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Amgen
Brigham and Women's Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services